| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 103.52B | 93.46B | 77.78B | 60.67B | 80.75B | 70.48B |
| Gross Profit | 22.63B | 22.94B | 21.72B | 16.03B | 19.07B | 18.95B |
| EBITDA | 4.88B | 4.93B | 9.31B | 817.87M | 762.60M | 4.25B |
| Net Income | 3.48B | 4.06B | 5.88B | -1.39B | -524.13M | 2.78B |
Balance Sheet | ||||||
| Total Assets | 119.30B | 133.15B | 120.33B | 122.77B | 122.72B | 123.66B |
| Cash, Cash Equivalents and Short-Term Investments | 48.99B | 52.76B | 53.89B | 54.90B | 49.85B | 56.66B |
| Total Debt | 21.10B | 22.65B | 17.99B | 12.19B | 7.51B | 7.99B |
| Total Liabilities | 51.36B | 61.70B | 48.13B | 45.24B | 40.69B | 44.47B |
| Stockholders Equity | 67.84B | 71.32B | 72.10B | 68.92B | 66.97B | 66.77B |
Cash Flow | ||||||
| Free Cash Flow | 2.43B | 8.41B | 10.28B | 8.92B | 2.61B | 9.52B |
| Operating Cash Flow | 2.91B | 9.45B | 11.16B | 9.84B | 4.33B | 10.52B |
| Investing Cash Flow | 4.99B | -9.38B | -3.98B | -8.47B | -24.88B | -14.98B |
| Financing Cash Flow | -7.97B | -5.79B | -6.96B | -1.21B | -1.07B | 25.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | HK$17.39B | 4.67 | 15.52% | 4.43% | 6.54% | 3.26% | |
78 Outperform | HK$106.73B | 22.77 | 23.11% | 2.92% | 10.31% | 8.93% | |
71 Outperform | HK$13.65B | 15.46 | 11.18% | 2.78% | -0.95% | 14.89% | |
66 Neutral | HK$20.03B | 30.82 | 1.68% | 4.94% | 7.23% | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | HK$138.74B | 42.51 | 4.29% | 2.22% | 25.03% | -15.27% | |
58 Neutral | HK$19.85B | 28.27 | 4.63% | 1.77% | 5.75% | -31.63% |